EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction

Holly L Sullivan, Yifei Liang iD, Kendra Worthington, Colin Luo, Nathan C Gianneschi iD, Karen L Christman iD

Biomacromolecules · 13.11.2023 · 24 (11) · 4695-4704

DOI: 10.1021/acs.biomac.3c00421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 11.09.2023. Verfasst von Holly L Sullivan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shu Chien-Gene Lay Department of Bioengineering and the Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, C…. Hauptthemen laut MEDLINE: Myocardial Infarction, Nanoparticles. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionNanoparticlesRatsAnimalsMatrix Metalloproteinase InhibitorsDrug Delivery SystemsPeptidesMicelles

Substanzen

Matrix Metalloproteinase InhibitorsPeptidesMicelles

Autor:innen und Institutionen

  • Shu Chien-Gene Lay Department of Bioengineering and the Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California 92093, United States.
  • Department of Chemistry, International Institute for Nanotechnology, Simpson-Querrey Institute, Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208, United States.
  • Departments of Materials Science & Engineering, Biomedical Engineering and Pharmacology, Northwestern University, Evanston, Illinois 60208, United States.
  • Department of Chemistry & Biochemistry, University of California San Diego, La Jolla, California 92093, United States.

ORCID-Profile: Yifei Liang, Nathan C Gianneschi, Karen L Christman

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Sullivan, H. L., Liang, Y., Worthington, K., Luo, C., Gianneschi, N. C., & Christman, K. L. (2023). Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction. Biomacromolecules, 24(11), 4695-4704. https://doi.org/10.1021/acs.biomac.3c00421

Vancouver

Sullivan HL, Liang Y, Worthington K, Luo C, Gianneschi NC, Christman KL. Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction. Biomacromolecules. 2023;24(11):4695-4704. doi:10.1021/acs.biomac.3c00421

BibTeX
@article{Sullivan2023,
  author = {Sullivan, Holly L and Liang, Yifei and Worthington, Kendra and Luo, Colin and Gianneschi, Nathan C and Christman, Karen L},
  title = {Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction},
  journal = {Biomacromolecules},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {4695--4704},
  doi = {10.1021/acs.biomac.3c00421}
}
Kostenlos starten →